Reconsidering clindamycin-rifampicin use in hidradenitis suppurativa: balancing anti-inflammatory benefits and resistance risk

Altunisik Toplu, SibelAltunisik, Nihal2026-04-042026-04-0420250307-69381365-2230https://doi.org/10.1093/ced/llaf357https://hdl.handle.net/11616/109198[No abstract available]eninfo:eu-repo/semantics/closedAccessReconsidering clindamycin-rifampicin use in hidradenitis suppurativa: balancing anti-inflammatory benefits and resistance riskLetter5012250525054073751910.1093/ced/llaf3572-s2.0-105022816328Q2WOS:001562524300001Q20000-0002-2915-4666